CAC Software vs Viz AAA

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by 4DMedical (Imbio CAC Software)
VS
by Viz.ai

AI Verdict

While both are FDA-cleared AI solutions for cardiovascular imaging analysis, they address different clinical needs. Imbio's CAC Software quantifies coronary artery calcification from non-contrast chest CTs for cardiovascular risk assessment. In contrast, Viz AAA focuses on the detection and triage of abdominal aortic aneurysms from CT angiography scans to accelerate care coordination.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary objective is to quantify coronary artery calcification from non-contrast chest CT scans for cardiovascular risk assessment. This tool is ideal for radiologists and cardiologists needing automated Agatston scores, arterial age, and 3D visualizations to support early detection and management of coronary artery disease.

View CAC Software →

Choose Viz AAA if…

Choose Viz AAA if your priority is the rapid detection, triage, and coordinated care for suspected Abdominal Aortic Aneurysm (AAA) cases. This solution is best suited for emergency medicine, radiology, and vascular surgery teams requiring AI-powered alerts and a HIPAA-compliant communication platform to accelerate treatment decisions and improve patient outcomes for acute aortic pathologies.

View Viz AAA →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software Viz AAA
Pricing Unknown Enterprise (hospital/health system)
Deployment Cloud-based (SaaS), integrates with PACS Cloud-based, integrates with PACS and EHR systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA offers a more comprehensive suite of usability features, including real-time alerts, a HIPAA-compliant communication platform, and mobile access to imaging and patient information, which extends beyond image processing to active care coordination for the entire care team. While CAC Software integrates well into existing DICOM workflows and operates automatically, Viz AAA's features facilitate faster action and collaboration across multidisciplinary teams.

Clinical Value

Viz AAA

Both tools offer significant clinical value in their distinct domains. However, Viz AAA's focus on the rapid detection and triage of suspected Abdominal Aortic Aneurysms (AAA), a time-critical and life-threatening condition, and its claim as the first FDA-cleared AI solution for this purpose, suggests a more immediate and impactful clinical benefit by accelerating treatment decisions and potentially preventing catastrophic events. CAC Software provides valuable quantitative risk assessment for coronary artery disease, but AAA detection and triage often require more urgent intervention.

Pricing & Value

Tie

Neither tool provides transparent public pricing, making a direct comparison of value difficult. Viz AAA specifies a subscription model based on the number of algorithms and population served, offering a slight indication of its pricing structure. However, without actual figures or clear pricing tiers for either product, it is impossible to definitively assess which offers better value.

Enterprise Readiness

CAC Software

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, CAC Software offers greater deployment flexibility, supporting cloud, on-premise, and integration with various partner platforms, which can be crucial for diverse hospital IT environments. Viz AAA is primarily cloud-based.

Innovation

Viz AAA

Viz AAA stands out as the 'first FDA-cleared AI-powered solution' for the detection and triage of suspected AAA, indicating a pioneering role in its specific application. Its comprehensive approach, integrating AI detection with real-time alerts and a secure communication platform for care coordination, represents a significant innovation in accelerating critical treatment decisions for a time-sensitive condition. While CAC Software utilizes deep learning and provides advanced quantification, Viz AAA's integrated workflow and regulatory achievement give it an edge.

Support & Docs

Viz AAA

Viz.ai provides a comprehensive 'Trust Center' with readily accessible documentation, including SOC 2 Type II Report, HIPAA Compliance Documentation, and ISO Certificates, demonstrating a high level of transparency regarding its security and privacy posture. They also offer a 'Help Center' and 'User Guides'. While Imbio provides phone and email support and offers user manuals upon request, Viz.ai's publicly available and extensive compliance documentation offers a more robust and transparent support ecosystem for enterprise customers.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software Viz AAA
Name CAC Software Viz AAA
Company Imbio Viz.ai
Primary Use Case Automated image post-processing to determine location and calculate amount of calcification within coronary arteries from non-contrast chest CT. AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.
Key Outputs / Specific Functionality Outputs Agatston score, arterial age, calcified lesion mass and volume; provides 3D visualizations and annotated images; integrates into existing DICOM viewing workflow. AI-powered automatic detection of suspected AAA; automated triage and prioritization of cases; real-time alerts to care teams; HIPAA-compliant communication platform; mobile access to high-fidelity imaging and patient information.
Specialties Cardiology, Radiology Emergency Medicine, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring CAC Software and Viz AAA.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's Coronary Artery Calcification (CAC) software is designed to help determine the location and calculate the amount of calcification within coronary arteries from non-contrast chest CTs. Viz AAA is an AI-powered solution for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, aiming to accelerate diagnosis and care coordination.
Imbio's CAC software analyzes non-contrast chest computed tomography (CT) scans. Viz AAA specifically utilizes CT angiography (CTA) scans for the detection and triage of suspected Abdominal Aortic Aneurysm.
Imbio's CAC software provides quantitative outputs such as Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. Viz AAA focuses on AI-powered automatic detection, automated triage, real-time alerts to care teams, and a HIPAA-compliant communication platform for multidisciplinary teams.
Imbio's CAC software is designed for cardiologists and radiologists. Viz AAA targets emergency medicine, radiology, and vascular surgery specialties.
Imbio's CAC software integrates into existing DICOM viewing workflows. Viz AAA integrates into existing hospital workflows and includes a HIPAA-compliant communication platform for multidisciplinary teams with mobile access to imaging and patient information.
Imbio's CAC software requires contacting the company directly for pricing information. Viz AAA operates on a subscription model, with an annual fee based on the number of algorithms used and the size of the population served.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.